09/09/2024 | Press release | Distributed by Public on 09/09/2024 11:43
PHILADELPHIA (September 9, 2024) - Registration for Paws for the Cause 2024, Fox Chase Cancer Center's ever-popular dog walk fundraiser, is now open. The event, now in its 25th year, will be held Sunday September 15, 2024, from 9 a.m. to noon in the Reimann parking lot.
The annual event features a one-mile walk around Fox Chase's Northeast Philadelphia campus, as well as food, music, children's activities, contests, prizes, and more. A variety of vendors and animal rescue organizations will also be on hand. The event is organized by Fox Chase's Board of Associates with generous support from title sponsor West Pharmaceutical Services Inc.
The 2024 dog walk will welcome Lori Giampaolo as its returning event chair and captain of Team Giampaolo, one of the event's top fundraising teams.
Annie Miyazaki-Grant, who serves on the Patient and Family Advisory Council at Fox Chase, will serve as the 2024 patient ambassador, along with her mini golden doodles Arthur and Ruby. Miyazaki-Grant was first introduced to Fox Chase through her friends, Drs. Jason and Emily Castellanos, and her participation with them at Paws for the Cause in 2021.
"Little did I know that a mere seven months later, I would be visiting Fox Chase again - this time, as a patient," Miyazaki-Grant said. "In March 2022, my sister and I were both diagnosed with breast cancer. I feel incredibly fortunate that I found my way to Fox Chase, where I have received truly the most amazing care."
Jason Castellanos, MD, MS, FACS, Assistant Professor in the Department of Surgical Oncology, and Emily Castellanos, MD, MPH, Adjunct Professor in the Department of Hematology/Oncology, will serve as the physician ambassadors for Paws for the Cause 2024.
"I love the sense of community here, and really, everything about Fox Chase," said Jason Castellanos. "Emily and I are excited to again take part in Paws for the Cause with our golden doodle, Bodie. We are also so pleased to be joined by our dear friend, Annie, and her family. Our dogs are great friends as well, and we expect this to be a memorable day for all."
Since its first year, Paws for the Cause has raised more than $950,000 for cancer research at Fox Chase. With support from the community, last year's event raised $119,000 to support cancer research.
Registration for Paws for the Cause 2024 is available by going to foxchase.org/giving/paws-cause. In addition, all are invited to follow Paws for the Cause on Facebook through the Fox Chase Ambassadors page to see sponsor and vendor highlights and to post photos of themselves and their pets supporting the event from afar.
Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation's first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center's nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.
For more information, call 888-369-2427